- Home
- EPAM vs RVTY Comparison
EPAM vs RVTY Comparison
Compare EPAM & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EPAM | RVTY |
|---|---|---|
| Founded | 1993 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 9.9B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | EPAM | RVTY |
|---|---|---|
| Price | $211.92 | $97.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $211.54 | $113.46 |
| AVG Volume (30 Days) | 887.9K | ★ 1.9M |
| Earning Date | 11-06-2025 | 01-30-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.55 | 1.99 |
| Revenue | ★ $5,297,859,000.00 | $2,813,367,000.00 |
| Revenue This Year | $17.39 | $5.33 |
| Revenue Next Year | $7.03 | $3.07 |
| P/E Ratio | ★ $31.93 | $48.32 |
| Revenue Growth | ★ 14.26 | 3.37 |
| 52 Week Low | $138.15 | $81.36 |
| 52 Week High | $269.00 | $128.29 |
Technical Indicators
Market Signals| Indicator | EPAM | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 71.90 | 48.81 |
| Support Level | $200.97 | $95.49 |
| Resistance Level | $214.43 | $100.16 |
| Average True Range (ATR) | 6.29 | 3.01 |
| MACD | -0.62 | -0.87 |
| Stochastic Oscillator | 88.42 | 24.80 |
Price Performance
Historical ComparisonAbout EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.